Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 698

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 698
---
 per share to give pro forma effect of both the Kintara Merger as well as the Mergers was calculated using the weighted average shares outstanding as calculated following the consummation of the Kintara Merger, and the issuance of additional shares in connection with the Mergers, assuming the shares were outstanding since January 1, 2024. As the Transactions are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net loss per share assumes that the shares issuable relating to the Transactions have been outstanding for the entirety of all periods presented.

454

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The unaudited pro forma condensed combined financial information has been prepared to present the Kineta Merger for the year ended December 31, 2024:

| Numerator:                                                                           |     | For the Year Ended    
 December 31, 2024 (1) |             |   |
|:-------------------------------------------------------------------------------------|:----|:----------------------|------------:|:--|
| Pro Forma Net loss attributable to common stockholders                               |     | $                     | (58,553,596 | ) |
| Denominator:                                                                         |     |                       |             |   |
| Weighted average shares outstanding - basic and diluted(2)                           |     |                       |  52,798,639 |   |
| Net loss per share:                                                                  |     |                       |             |   |
| Pro forma net loss attributable to common stockholders per share - basic and diluted |     | $                     |       (1.11 | ) |
| Excluded securities:                                                                 |     |                       |             |   |
| TuHURA Options(2)                                                                    |     |                       |   6,587,057 |   |
| CVR Shares(2)                                                                        |     |                       |   1,539,938 |   |
| TuHURA Warrants(2)                                                                   |     |                       |   9,213,983 |   |

| (1) | Pro forma net loss attributable to common stockholders includes the related pro forma adjustments as referred to within the section “Unaudited Pro Forma Condensed Combined Financial Information.” |

| (2) | The potentially dilutive outstanding securities were excluded from the computation of pro forma net loss attributable to common stockholders per share, basic and diluted, because their effect would have been anti-d